Bio-Techne Corporation
TECH | NASDAQ
$72.67
+$0.01 (+0.01%)
At close: Nov 2, 2026, 4:00 PM ET
$72.76
+$0.07 (+0.10%)
Pre-market:
Nov 2, 2026, 9:28 AM ET
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 1.22B | 1.22B | 1.16B | 1.14B | 1.11B | 931.03M |
Cost of Revenue | 415.97M | 429.36M | 389.34M | 366.89M | 349.1M | 298.18M |
Gross Profit | 799.07M | 790.27M | 769.73M | 769.82M | 756.5M | 632.85M |
Operating Income | 251.89M | 102.26M | 206.69M | 298.94M | 296.59M | 237.3M |
Interest Income | n/a | 3.89M | 3.32M | 3.41M | 794K | 473K |
Pretax Income | 240.68M | 98.46M | 185.69M | 338.66M | 301.39M | 148.18M |
Net Income | 181.86M | 73.4M | 168.11M | 285.26M | 272.05M | 140.41M |
Selling & General & Admin | 452.42M | 415.1M | 393.32M | 352.44M | 339M | 289.92M |
Research & Development | 94.77M | 99.5M | 96.66M | 92.49M | 87.14M | 70.6M |
Other Expenses | n/a | 173.42M | 73.06M | 25.94M | 33.77M | 35.03M |
Operating Expenses | 547.18M | 688.02M | 563.04M | 470.87M | 459.91M | 395.55M |
Interest Expense | 5.41M | 8.51M | 15.74M | 11.22M | 11.31M | 13.95M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 963.15M | 1.12B | 952.37M | 837.76M | 809.01M | 693.74M |
Income Tax Expense | 58.82M | 25.06M | 17.58M | 53.22M | 38.29M | 8.59M |
Shares Outstanding (Basic) | 155.96M | 157.52M | 157.71M | 157.18M | 156.88M | 154.99M |
Shares Outstanding (Diluted) | 157.01M | 159.72M | 160.77M | 161.86M | 164.12M | 161.93M |
EPS (Basic) | 1.17 | 0.47 | 1.07 | 1.81 | 1.73 | 0.91 |
EPS (Diluted) | 1.16 | 0.46 | 1.05 | 1.76 | 1.66 | 0.87 |
EBITDA | 343.44M | 216.88M | 313.14M | 457.11M | 413.76M | 249.87M |
EBIT | 246.09M | 106.97M | 201.43M | 349.87M | 312.7M | 162.13M |
Depreciation & Amortization | 97.36M | 109.9M | 111.71M | 107.24M | 101.07M | 87.75M |
Add to Watchlist
Select watchlists to add or remove TECH